Royalty Pharma plc
RPRX
Rang in Aktien
#860
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Aktienkurs
$62.20
Zuletzt synchronisiert: 2026-10-21
Marktkapitalisierung
$27.69B
Veränderung (1 Tag)
-0.09%
Veränderung (1 Jahr)
68.82%
Land
US
Handel Royalty Pharma plc (RPRX)
Kategorie
Healthcare
Kursverlauf für Royalty Pharma plc (RPRX)
Höchster Schlusskurs: $58.43 am 2026-10-01
Niedrigster Schlusskurs: $49.50 am 2020-06-01
Niedrigster Schlusskurs: $49.50 am 2020-06-01
Kursverlauf der Aktie von Royalty Pharma plc von 2020 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 27.24% |
| 2025 | 52.96% |
| 2024 | -9.35% |
| 2023 | -31.53% |
| 2022 | 5.51% |
| 2021 | -14.39% |
| 2020 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $46.29 | 37.83% |
SE
|
|
| $171.04 | 23.67% |
FR
|
|
| $116.39 | 58.03% |
US
|
|
| $59.46 | -0.57% |
IT
|
|
| $0.65 | -30.33% |
HK
|
